Mersana Therapeutics, Inc. (Nasdaq:MRSN)
Health Care/Life Sciences • Biotechnology
CIK 1442836
Company
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
Address
840 Memorial Drive
Cambridge, Massachusetts 02139
840 Memorial Drive
Cambridge, Massachusetts 02139
Employees
123
123
Stock Info
Close
$0.5124
$0.5124
Day Range
0.4934 - 0.5280
0.4934 - 0.5280
52 Week Range
0.4625 - 6.2801
0.4625 - 6.2801
Average volume
5.04M
5.04M
Short Interest
9.15M (02/14/25)
9.15M (02/14/25)
% of Float Shorted
10.67%
10.67%
Market Cap
$63.86M
$63.86M
Revenue
$36.86M
$36.86M
Net Income
-$171.67M
-$171.67M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director Martin H. Huber |
Director Anna Protopapas |
Chairman David M. Mott |
Independent Director Willard H. Dere |
Independent Director Lawrence M. Alleva |
Independent Director Allene M. Diaz |
Independent Director Andrew A. F. Hack |
Independent Director Kristen M. Hege |
SEC filings
Date | Form | Event |
---|---|---|
19 Dec, 2024 | 8-K | |
15 Nov, 2024 | SC 13D/A | |
14 Nov, 2024 | SC 13G/A | |
14 Nov, 2024 | SC 13G/A | |
13 Nov, 2024 | 10-Q | |
13 Nov, 2024 | 8-K | |
29 Oct, 2024 | 144 | |
29 Oct, 2024 | 4 | |
15 Oct, 2024 | SC 13G/A | |
7 Oct, 2024 | 144 | |
7 Oct, 2024 | 4 | |
7 Oct, 2024 | 4 | |
7 Oct, 2024 | 4 | |
7 Oct, 2024 | 4 | |
7 Oct, 2024 | 4 | |
7 Oct, 2024 | 144 | |
7 Oct, 2024 | 144 | |
7 Oct, 2024 | 144 | |
3 Oct, 2024 | 4 | |
13 Sep, 2024 | 4 | |
13 Sep, 2024 | 144 | |
13 Aug, 2024 | 10-Q | |
13 Aug, 2024 | 8-K | |
2 Jul, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
11 Jun, 2024 | 8-K | |
17 May, 2024 | SC 13G | |
9 May, 2024 | 424B5 | |
9 May, 2024 | 8-K | |
9 May, 2024 | EFFECT | |
9 May, 2024 | 10-Q | |
26 Apr, 2024 | ARS | |
26 Apr, 2024 | DEFA14A | |
26 Apr, 2024 | DEF 14A | |
3 Apr, 2024 | 4 | |
28 Feb, 2024 | 8-K | |
28 Feb, 2024 | 8-K | |
28 Feb, 2024 | 424B5 | |
28 Feb, 2024 | POSASR | |
28 Feb, 2024 | 10-K | |
28 Feb, 2024 | POS AM | |
16 Feb, 2024 | 4/A | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G | |
14 Feb, 2024 | SC 13G | |
14 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | SC 13G | |
29 Jan, 2024 | SC 13G/A | |
22 Jan, 2024 | SC 13G/A | |
17 Jan, 2024 | 4 | |
17 Jan, 2024 | 4 | |
17 Jan, 2024 | 4 | |
17 Jan, 2024 | 4 | |
17 Jan, 2024 | 4 | |
17 Jan, 2024 | 4 | |
17 Jan, 2024 | 4 | |
17 Jan, 2024 | 4 | |
16 Jan, 2024 | 144 | |
16 Jan, 2024 | 144 | |
16 Jan, 2024 | 144 | |
16 Jan, 2024 | 144 | |
12 Jan, 2024 | S-8 | |
5 Jan, 2024 | 8-K | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
21 Dec, 2023 | 8-K | |
7 Nov, 2023 | 10-Q | |
7 Nov, 2023 | 8-K | |
31 Oct, 2023 | 8-K | |
27 Oct, 2023 | 4 | |
4 Oct, 2023 | 4 | |
4 Oct, 2023 | 4 | |
4 Oct, 2023 | 4 | |
4 Oct, 2023 | 4 | |
4 Oct, 2023 | 4 | |
13 Sep, 2023 | 4 | |
13 Sep, 2023 | 4 | |
12 Sep, 2023 | 8-K | |
7 Sep, 2023 | 4 | |
7 Sep, 2023 | 3 | |
7 Sep, 2023 | 4 | |
7 Sep, 2023 | 4 | |
7 Sep, 2023 | 4 | |
7 Sep, 2023 | 4 | |
6 Sep, 2023 | 8-K | CEO Change |
18 Aug, 2023 | 4 | |
8 Aug, 2023 | 10-Q | |
8 Aug, 2023 | 8-K | |
7 Aug, 2023 | SC 13G | |
31 Jul, 2023 | 3 | |
27 Jul, 2023 | SC 13G | |
27 Jul, 2023 | 8-K | |
6 Jul, 2023 | 4 | |
6 Jul, 2023 | 4 | |
6 Jul, 2023 | 4 | |
6 Jul, 2023 | 4 | |
6 Jul, 2023 | 4 | |
15 Jun, 2023 | 8-K | |
12 Jun, 2023 | 4 | |
12 Jun, 2023 | 4 | |
12 Jun, 2023 | 4 | |
12 Jun, 2023 | 4 | |
12 Jun, 2023 | 4 | |
12 Jun, 2023 | 4 | |
12 Jun, 2023 | 4 | |
9 Jun, 2023 | 8-K | |
9 May, 2023 | 8-K | |
9 May, 2023 | S-3ASR | |
9 May, 2023 | 10-Q | |
28 Apr, 2023 | DEF 14A | |
28 Apr, 2023 | 4 | |
28 Apr, 2023 | ARS | |
28 Apr, 2023 | DEFA14A | |
14 Apr, 2023 | PRE 14A | |
5 Apr, 2023 | 4 | |
5 Apr, 2023 | 4 | |
5 Apr, 2023 | 4 | |
5 Apr, 2023 | 4 | |
5 Apr, 2023 | 4 | |
31 Mar, 2023 | 8-K | |
24 Mar, 2023 | 8-K | |
13 Mar, 2023 | 8-K | |
28 Feb, 2023 | 8-K | |
28 Feb, 2023 | S-8 | |
28 Feb, 2023 | 10-K | |
14 Feb, 2023 | SC 13G | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G/A | |
6 Feb, 2023 | SC 13G/A | |
3 Feb, 2023 | SC 13G/A | |
1 Feb, 2023 | 8-K | |
31 Jan, 2023 | SC 13G/A | |
25 Jan, 2023 | 8-K | |
19 Jan, 2023 | SC 13G/A | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
6 Jan, 2023 | 8-K | |
27 Dec, 2022 | 8-K | |
22 Dec, 2022 | 8-K | |
16 Dec, 2022 | 4 | |
2 Dec, 2022 | 4 | |
7 Nov, 2022 | 8-K | |
7 Nov, 2022 | 10-Q | |
7 Nov, 2022 | 424B5 | |
7 Nov, 2022 | 8-K | |
6 Oct, 2022 | 8-K | |
18 Aug, 2022 | 4 | |
16 Aug, 2022 | 8-K | |
8 Aug, 2022 | 8-K | |
8 Aug, 2022 | 10-Q | |
8 Aug, 2022 | 8-K | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 8-K | |
10 Jun, 2022 | 4 | |
10 Jun, 2022 | 4 | |
2 Jun, 2022 | 4 | |
26 May, 2022 | 4 | |
23 May, 2022 | 4 | |
18 May, 2022 | 4 | |
11 May, 2022 | SC 13D/A | |
9 May, 2022 | 10-Q | |
9 May, 2022 | 8-K | |
29 Apr, 2022 | DEFA14A | |
29 Apr, 2022 | DEF 14A | |
28 Apr, 2022 | 4 | |
18 Apr, 2022 | PRE 14A | |
14 Apr, 2022 | SC 13D/A | |
14 Apr, 2022 | 4 | |
13 Apr, 2022 | 4 | |
28 Feb, 2022 | 8-K | |
28 Feb, 2022 | 8-K | |
28 Feb, 2022 | 424B5 | |
28 Feb, 2022 | 10-K | |
28 Feb, 2022 | S-8 | |
17 Feb, 2022 | SC 13G | |
11 Feb, 2022 | SC 13G | |
10 Feb, 2022 | SC 13G | |
8 Feb, 2022 | SC 13D/A | |
8 Feb, 2022 | 4 | |
4 Feb, 2022 | SC 13G/A | |
3 Feb, 2022 | 8-K | |
27 Jan, 2022 | SC 13G | |
26 Jan, 2022 | SC 13G/A | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
19 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
4 Jan, 2022 | 4 | |
3 Jan, 2022 | 4 | |
3 Jan, 2022 | SC 13D/A | |
20 Dec, 2021 | 4 | |
2 Dec, 2021 | 4 | |
23 Nov, 2021 | 8-K | |
18 Nov, 2021 | EFFECT | |
16 Nov, 2021 | CORRESP | |
15 Nov, 2021 | UPLOAD | |
9 Nov, 2021 | 8-K | |
9 Nov, 2021 | S-3 | |
9 Nov, 2021 | 10-Q | |
29 Oct, 2021 | 8-K | |
16 Sep, 2021 | SC 13G | |
10 Sep, 2021 | 8-K | |
24 Aug, 2021 | 4 | |
18 Aug, 2021 | 4 | |
18 Aug, 2021 | 3 | |
16 Aug, 2021 | 8-K | |
6 Aug, 2021 | 8-K | |
6 Aug, 2021 | 10-Q | |
22 Jul, 2021 | 4 | |
19 Jul, 2021 | 4 | |
19 Jul, 2021 | 4 | |
19 Jul, 2021 | 4 | |
9 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
23 Jun, 2021 | 4 | |
17 Jun, 2021 | 8-K | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
24 May, 2021 | 4 | |
10 May, 2021 | 8-K | |
10 May, 2021 | S-8 | |
10 May, 2021 | 10-Q | |
28 Apr, 2021 | 4 | |
28 Apr, 2021 | 3 | |
27 Apr, 2021 | DEFA14A | |
27 Apr, 2021 | DEF 14A | |
22 Apr, 2021 | 4 | |
9 Apr, 2021 | 8-K | |
24 Mar, 2021 | 4 | |
11 Mar, 2021 | 4 | |
11 Mar, 2021 | 3 | |
11 Mar, 2021 | 8-K | |
26 Feb, 2021 | 10-K | |
26 Feb, 2021 | 8-K | |
24 Feb, 2021 | 4 | |
12 Feb, 2021 | SC 13G | |
12 Feb, 2021 | SC 13G/A | |
11 Feb, 2021 | SC 13G/A | |
4 Feb, 2021 | SC 13G | |
27 Jan, 2021 | SC 13G/A | |
25 Jan, 2021 | SC 13G | |
22 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
20 Jan, 2021 | 4 | |
12 Jan, 2021 | 4 | |
12 Jan, 2021 | SC 13D/A | |
6 Jan, 2021 | 4 | |
5 Jan, 2021 | 8-K |
Last update:2025-03-06 12:20:33.613814
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.